Researchers have identified CTHRC1 as a novel biomarker to predict immunotherapy response in colorectal cancer.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
New Biomarker Identified to Predict Immunotherapy Success in Colon and
Poorer Survival CTHRC1 expression linked to
5% patients eligible for immunotherapy